Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers-Reference-Cited by-同舟云学术

Influence of chronic kidney disease and haemodialysis treatment on pharmacokinetics of nebivolol enantiomers

Published:2016-04-07 Issue:1 Volume:82 Page:83-91
ISSN:0306-5251
Container-title:British Journal of Clinical Pharmacology
language:en
Short-container-title:Br J Clin Pharmacol

Author:

Neves Daniel V.¹,Lanchote Vera L.¹,Moysés Neto Miguel²,Cardeal da Costa José A.²,Vieira Carolina P.¹,Coelho Eduardo B.²

Affiliation:

1. Department of Clinical Analysis, Food Science and Toxicology, School of Pharmaceutical Sciences of Ribeirão Preto; University of São Paulo; Ribeirão Preto SP Brazil

2. Department of Internal Medicine, School of Medicine of Ribeirão Preto; University of São Paulo; Ribeirão Preto SP Brazil

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/bcp.12917/fullpdf

Reference40 articles.

1. Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis;Velenosi;Expert Opin Drug Metab Toxicol,2014

2. Emerging evidence of the impact of kidney disease on drug metabolism and transport;Nolin;Clin Pharmacol Ther,2008

3. The influence of chronic renal failure on drug metabolism and transport;Dreisbach;Clin Pharmacol Ther,2009

4. Application of a physiologically based pharmacokinetic model informed by a top-down approach for the prediction of pharmacokinetics in chronic kidney disease patients;Sayama;AAPS J,2014

5. Downregulation of hepatic acetylation of drugs in chronic renal failure;Simard;J Am Soc Nephrol,2008

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Influence of Different Types of β-Blockers on Mortality in Patients on Hemodialysis;Biomedicines;2023-10-19

2. Clinical pharmacokinetics of nebivolol: a systematic review;Drug Metabolism Reviews;2023-10-02

3. Heart Failure in Patients with Chronic Kidney Disease;Journal of Clinical Medicine;2023-09-21

4. Evaluation of Renal Impairment Influence on Metabolic Drug Clearance using a Modelling Approach;Clinical Pharmacokinetics;2023-01-11

5. Does nebivolol have renoprotective action in patients with chronic kidney disease conditions? An integrative review;European Journal of Pharmacology;2021-08